Prospective of 68Ga-Radiopharmaceutical Development

Theranostics- Canada

doi 10.7150/thno.7447

Full Text

Abstract

Available in

Categories

Date

January 1, 2014

Authors

Publisher

Ivyspring International Publisher

Related search

[68Ga]Ga-Dota-Toc: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging

Pharmaceuticals

Molecular Medicine

Pharmaceutical Science

English

Meningiomas: A Comparative Study of 68Ga-Dotatoc, 68Ga-Dotanoc and 68Ga-Dotatate for Molecular Imaging in Mice

Multidisciplinary

English

Selected 68Ga-Siderophores Versus 68Ga-Colloid and 68Ga-Citrate: Biodistribution and Small Animal Imaging in Mice

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia

Molecular Biology

English

Prospective Study of 68Ga-Nota-Nfb: Radiation Dosimetry in Healthy Volunteers and First Application in Glioma Patients

English

Comprehensive Quality Control of the ITG 68Ge/68Ga Generator and Synthesis of 68Ga-Dotatoc and 68Ga-Psma-Hbed-Cc for Clinical Imaging

Journal of Nuclear Medicine

Nuclear Medicine

English

23rd International Symposium on Radiopharmaceutical Sciences

Journal of Labelled Compounds and Radiopharmaceuticals

Organic Chemistry

Nuclear Medicine

Analytical Chemistry

English

The Importance of Radiopharmaceutical Chemistry for the Development of Nuclear Medicine: A Message From the Associate Editor

Nuclear Medicine and Molecular Imaging

Nuclear Medicine

English

Radiopharmaceutical Therapy in the Era of Precision Medicine

European Journal of Cancer

Cancer Research

English

Comparative Biodistribution and Radiation Dosimetry of 68Ga-Dotatoc and 68Ga-Dotatate in Patients With Neuroendocrine Tumors

Journal of Nuclear Medicine

Nuclear Medicine

English